全文获取类型
收费全文 | 120328篇 |
免费 | 45179篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 1995篇 |
儿科学 | 5480篇 |
妇产科学 | 1554篇 |
基础医学 | 21213篇 |
口腔科学 | 6044篇 |
临床医学 | 17425篇 |
内科学 | 31036篇 |
皮肤病学 | 8088篇 |
神经病学 | 17962篇 |
特种医学 | 4073篇 |
外国民族医学 | 4篇 |
外科学 | 19757篇 |
综合类 | 774篇 |
一般理论 | 55篇 |
预防医学 | 8467篇 |
眼科学 | 2384篇 |
药学 | 8547篇 |
2篇 | |
中国医学 | 1059篇 |
肿瘤学 | 9632篇 |
出版年
2021年 | 1794篇 |
2020年 | 5298篇 |
2019年 | 11264篇 |
2018年 | 10599篇 |
2017年 | 11886篇 |
2016年 | 12534篇 |
2015年 | 12468篇 |
2014年 | 12564篇 |
2013年 | 13537篇 |
2012年 | 5832篇 |
2011年 | 5860篇 |
2010年 | 9906篇 |
2009年 | 6173篇 |
2008年 | 3709篇 |
2007年 | 2766篇 |
2006年 | 2707篇 |
2005年 | 2388篇 |
2004年 | 2388篇 |
2003年 | 2245篇 |
2002年 | 2391篇 |
2001年 | 2271篇 |
2000年 | 2246篇 |
1999年 | 1632篇 |
1998年 | 555篇 |
1997年 | 509篇 |
1996年 | 494篇 |
1995年 | 471篇 |
1994年 | 413篇 |
1992年 | 1180篇 |
1991年 | 1186篇 |
1990年 | 1105篇 |
1989年 | 1108篇 |
1988年 | 916篇 |
1987年 | 1042篇 |
1986年 | 967篇 |
1985年 | 976篇 |
1984年 | 773篇 |
1983年 | 630篇 |
1982年 | 402篇 |
1981年 | 372篇 |
1980年 | 375篇 |
1979年 | 714篇 |
1978年 | 531篇 |
1977年 | 450篇 |
1976年 | 465篇 |
1975年 | 401篇 |
1974年 | 530篇 |
1973年 | 469篇 |
1972年 | 392篇 |
1971年 | 372篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
51.
52.
53.
The diagnosis of hysteria is often incorrect and must be made with great caution. A retrospective study demonstrates that an erroneous diagnosis of hysteria is most likely to be given to females, the psychiatrically ill, patients who embellish and patients who present plausible psychogenic explanations for their illness. Movement disorders and paralysis are the neurologic disorders most frequently mislabeled as hysteria. 相似文献
54.
Practical management of patients with non-small-cell lung cancer treated with gefitinib. 总被引:7,自引:0,他引:7
Neelam T Shah Mark G Kris William Pao Leslie B Tyson Barbara M Pizzo Murk-Hein Heinemann Leah Ben-Porat Dana L Sachs Robert T Heelan Vincent A Miller 《Journal of clinical oncology》2005,23(1):165-174
PURPOSE: The use of gefitinib, the first drug approved to inhibit the epidermal growth factor receptor tyrosine kinase, is indicated in patients with non-small-cell lung cancer with tumors progressive after chemotherapy. The unique mechanism of action of this agent leads to distinctive patterns of response and toxicity in persons with lung cancer. Many of the principles of management relevant to gefitinib are distinct from those with conventional cytotoxic drugs. To meet this need, we present practical guidelines on the use of gefitinib in patients with non-small-cell lung cancer. METHODS: This article reviews gefitinib's indications, dosing, response phenomena, and patterns of relapse in individuals with radiographic response. RESULTS: We present our recommendations for the management of rash and diarrhea caused by this agent. CONCLUSION: This information can guide practitioners and help them inform their patients about what to expect when they receive gefitinib. 相似文献
55.
1 The internal anal sphincter (IAS) has a spontaneous tone and is the main contributor to the maintenance of faecal continence. The spontaneous resting tone exhibited by the sphincter can be modified by neurotransmitters from the autonomic and enteric nervous systems. 2 In this review, the influence of the sympathetic and parasympathetic nervous systems on IAS tone are discussed and the putative roles of nitric oxide, carbon monoxide, vasoactive intestinal peptide and adenosine triphosphate in non‐adrenergic non‐cholinergic transmission are considered. 3 Faecal incontinence is a common condition that places a heavy financial burden on the health service and severely affects patients’ quality of life. Resting anal pressure is reduced in patients with faecal incontinence and agents that increase sphincter tone tend to relieve symptoms. The results of clinical studies of the use of phenylephrine to treat faecal incontinence are reviewed. 4 It is concluded that the IAS is a potential target for drug development for the treatment of faecal incontinence. 相似文献
56.
57.
58.
59.
60.